Fingerprint
Dive into the research topics of 'Post-operative radiotherapy (PORT) or chemoradiotherapy (CPORT) following resection of stages II and IIIA non-small cell lung cancer (NSCLC) does not increase the expected risk of death from intercurrent disease (DID) in Eastern Cooperative Oncology Group (ECOG) trial E3590'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically